Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Stem Cell Reports ; 14(3): 390-405, 2020 03 10.
Article in English | MEDLINE | ID: mdl-32084385

ABSTRACT

In amyotrophic lateral sclerosis (ALS) motor neurons (MNs) undergo dying-back, where the distal axon degenerates before the soma. The hexanucleotide repeat expansion (HRE) in C9ORF72 is the most common genetic cause of ALS, but the mechanism of pathogenesis is largely unknown with both gain- and loss-of-function mechanisms being proposed. To better understand C9ORF72-ALS pathogenesis, we generated isogenic induced pluripotent stem cells. MNs with HRE in C9ORF72 showed decreased axonal trafficking compared with gene corrected MNs. However, knocking out C9ORF72 did not recapitulate these changes in MNs from healthy controls, suggesting a gain-of-function mechanism. In contrast, knocking out C9ORF72 in MNs with HRE exacerbated axonal trafficking defects and increased apoptosis as well as decreased levels of HSP70 and HSP40, and inhibition of HSPs exacerbated ALS phenotypes in MNs with HRE. Therefore, we propose that the HRE in C9ORF72 induces ALS pathogenesis via a combination of gain- and loss-of-function mechanisms.


Subject(s)
Axons/metabolism , C9orf72 Protein/genetics , DNA Repeat Expansion/genetics , Gene Knockout Techniques , HSP40 Heat-Shock Proteins/metabolism , HSP70 Heat-Shock Proteins/metabolism , Amyotrophic Lateral Sclerosis/genetics , Amyotrophic Lateral Sclerosis/pathology , Apoptosis/drug effects , Axons/drug effects , Benzhydryl Compounds/pharmacology , C9orf72 Protein/metabolism , Cell Differentiation/drug effects , Cytoplasmic Granules/drug effects , Cytoplasmic Granules/metabolism , Gain of Function Mutation/genetics , Humans , Induced Pluripotent Stem Cells/drug effects , Induced Pluripotent Stem Cells/metabolism , Models, Biological , Motor Neurons/drug effects , Motor Neurons/metabolism , Motor Neurons/pathology , Nerve Degeneration/pathology , Pyrrolidinones/pharmacology , Transcriptome/genetics
2.
SLAS Discov ; 24(3): 234-241, 2019 03.
Article in English | MEDLINE | ID: mdl-30616488

ABSTRACT

Phenotypic screens using automated microscopy allow comprehensive measurement of the effects of compounds on cells due to the number of markers that can be scored and the richness of the parameters that can be extracted. The high dimensionality of the data is both a rich source of information and a source of noise that might hide information. Many methods have been proposed to deal with this complex data in order to reduce the complexity and identify interesting phenotypes. Nevertheless, the majority of laboratories still only use one or two parameters in their analysis, likely due to the computational challenges of carrying out a more sophisticated analysis. Here, we present a novel method that allows discovering new, previously unknown phenotypes based on negative controls only. The method is compared with L1-norm regularization, a standard method to obtain a sparse matrix. The analytical pipeline is implemented in the open-source software KNIME, allowing the implementation of the method in many laboratories, even ones without advanced computing knowledge.


Subject(s)
Pharmacology , Phenotype , Automation , Microscopy/methods , Software
3.
Methods Mol Biol ; 1953: 43-60, 2019.
Article in English | MEDLINE | ID: mdl-30912015

ABSTRACT

High-content screening (HCS) has established itself in the world of the pharmaceutical industry as an essential tool for drug discovery and drug development. HCS is currently starting to enter the academic world and might become a widely used technology. Given the diversity of problems tackled in academic research, HCS could experience some profound changes in the future, mainly with more imaging modalities and smart microscopes being developed. One of the limitations in the establishment of HCS in academia is flexibility and cost. Flexibility is important to be able to adapt the HCS setup to accommodate the multiple different assays typical of academia. Many cost factors cannot be avoided, but the costs of the software packages necessary to analyze large datasets can be reduced by using open-source software. We present and discuss the open-source software CellProfiler for image analysis and KNIME for data analysis and data mining that provide software solutions, which increase flexibility and keep costs low.


Subject(s)
Drug Evaluation, Preclinical/methods , High-Throughput Screening Assays/methods , Image Processing, Computer-Assisted/methods , Software , Animals , Drug Discovery/methods , Humans , Workflow
4.
Stem Cell Reports ; 12(3): 502-517, 2019 03 05.
Article in English | MEDLINE | ID: mdl-30773488

ABSTRACT

Neuroinflammation is a hallmark of neurological disorders and is accompanied by the production of neurotoxic agents such as nitric oxide. We used stem cell-based phenotypic screening and identified small molecules that directly protected neurons from neuroinflammation-induced degeneration. We demonstrate that inhibition of CDK5 is involved in, but not sufficient for, neuroprotection. Instead, additional inhibition of GSK3ß is required to enhance the neuroprotective effects of CDK5 inhibition, which was confirmed using short hairpin RNA-mediated knockdown of CDK5 and GSK3ß. Quantitative phosphoproteomics and high-content imaging demonstrate that neurite degeneration is mediated by aberrant phosphorylation of multiple microtubule-associated proteins. Finally, we show that our hit compound protects neurons in vivo in zebrafish models of motor neuron degeneration and Alzheimer's disease. Thus, we demonstrate an overlap of CDK5 and GSK3ß in mediating the regulation of the neuronal cytoskeleton and that our hit compound LDC8 represents a promising starting point for neuroprotective drugs.


Subject(s)
Cyclin-Dependent Kinase 5/metabolism , Cytoskeleton/metabolism , Glycogen Synthase Kinase 3 beta/metabolism , Inflammation/metabolism , Nerve Degeneration/metabolism , Neurons/metabolism , Alzheimer Disease/drug therapy , Alzheimer Disease/metabolism , Animals , Cytoskeleton/drug effects , Humans , Inflammation/drug therapy , Microtubules/drug effects , Microtubules/metabolism , Nerve Degeneration/drug therapy , Neurites/drug effects , Neurites/metabolism , Neurons/drug effects , Neuroprotective Agents/pharmacology , Phosphorylation/drug effects , Signal Transduction/drug effects , Zebrafish/metabolism
5.
Stem Cell Reports ; 10(2): 375-389, 2018 02 13.
Article in English | MEDLINE | ID: mdl-29358088

ABSTRACT

Perturbations in stress granule (SG) dynamics may be at the core of amyotrophic lateral sclerosis (ALS). Since SGs are membraneless compartments, modeling their dynamics in human motor neurons has been challenging, thus hindering the identification of effective therapeutics. Here, we report the generation of isogenic induced pluripotent stem cells carrying wild-type and P525L FUS-eGFP. We demonstrate that FUS-eGFP is recruited into SGs and that P525L profoundly alters their dynamics. With a screening campaign, we demonstrate that PI3K/AKT/mTOR pathway inhibition increases autophagy and ameliorates SG phenotypes linked to P525L FUS by reducing FUS-eGFP recruitment into SGs. Using a Drosophila model of FUS-ALS, we corroborate that induction of autophagy significantly increases survival. Finally, by screening clinically approved drugs for their ability to ameliorate FUS SG phenotypes, we identify a number of brain-penetrant anti-depressants and anti-psychotics that also induce autophagy. These drugs could be repurposed as potential ALS treatments.


Subject(s)
Amyotrophic Lateral Sclerosis/genetics , Drosophila Proteins/genetics , Heterogeneous-Nuclear Ribonucleoprotein Group F-H/genetics , Induced Pluripotent Stem Cells/metabolism , RNA-Binding Protein FUS/genetics , Amyotrophic Lateral Sclerosis/metabolism , Amyotrophic Lateral Sclerosis/pathology , Animals , Antidepressive Agents/pharmacology , Antipyretics/pharmacology , Autophagy/genetics , CRISPR-Cas Systems , Drosophila , Drug Evaluation, Preclinical , Green Fluorescent Proteins/genetics , Humans , Motor Neurons/metabolism , Motor Neurons/pathology , Mutation , Phosphatidylinositol 3-Kinases/genetics , Proto-Oncogene Proteins c-akt/genetics , Signal Transduction/drug effects , TOR Serine-Threonine Kinases/genetics
SELECTION OF CITATIONS
SEARCH DETAIL